Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Andreas Schneeweiß(Heidelberg University), Stephen Chia(BC Cancer Agency), Tamas Hickish(Royal Bournemouth Hospital), V. Harvey(Auckland City Hospital), Alexandru Eniu(Institute of Oncology Prof. Dr. Ion Chiricuta), Roberto Hegg(Hospital da Mulher São Paulo), Christoph Tausch(Breast Center), Jae Hong Seo(Korea University Medical Center), Y.-F. Tsai(Taipei Veterans General Hospital), Jayantha Ratnayake(Roche (United Kingdom)), Virginia McNally(Roche (United Kingdom)), G. Ross(Roche (United Kingdom)), Javier Cortés(Vall d'Hebron Hospital Universitari)
Cited by 1,266
Abstract
Related Papers
No related papers found
Powered by citation graph analysis